The value of positron
emission tomography in early detection
of lung cancer in high-risk population: a
systematic review:[ü°èÀû°íÂû] °íÀ§Ç豺ÀÇ Æó¾Ï ÃʱâÁø´ÜÀ»
À§ÇÑ PET ¿ªÇÒ Chang, C. Y., Chang, S. J., Chang, S. C.,
& Yuan, M. K. The clinical respiratory journal 2013 7 1
1-6 / 10.1111/j.1752-699X.2012.00290.x
Evaluation of
diagnostic accuracy of DNA methylation biomarkers for bladder cancer: a
systematic review and meta-analysis:[ü°èÀû°íÂû°ú ¸ÞŸºÐ¼®] ¹æ±¤¾ÏÀÇ DNA methylation ¹ß¾ÏÇ¥½ÄÀÚÀÇ Áø´ÜÁ¤È®¼º Æò°¡ Chen, H., Yu, Y., Rong, S., &Wang, H. 10.3109/1354750X.2014.889211 / 2014 19 3
189-97
The value of serum
Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung
cancer: a meta-analysis:[¸ÞŸºÐ¼®] ¼Ò¼¼Æ÷Æó¾Ï(NSCLC) Áø´Ü¿¡¼ ¹ß¾ÏÇ¥½ÄÀÚ, Ç÷û Cyfra21-1 Æò°¡
10.4103/0973-1482.145835 / 2014 10
Suppl C131-4 Cui, C., Sun, X., Zhang, J., Han, D., &
Gu, J.
Role of MRI in
detecting involvement of the uterine internal os in uterine cervical cancer:
systematic review of diagnostic test accuracy: [ü°èÀû°íÂû] ÀڱðæºÎ¾ÏÀÇ Àڱó»ºÎ ¿¬·ç ¹ß°ßÀ» À§ÇÑ MRI¿ªÇÒ
de Boer, P., Adam, J. A., Buist, M. R., van
de Vijver, M. J., Rasch, C. R., Stoker, J., Bipat, S., & Stalpers, L. J. 10.1016/j.ejrad.2013.04.027
2013 82 9 e422-8
Comparison of FDG
PET/CT and gadolinium-enhanced MRI for the detection of bone metastases in
patients with cancer: a meta-analysis: [¸ÞŸºÐ¼®] ¾ÏȯÀÚÀÇ
°ñ ÀüÀÌ ±¸ºÐÀ» À§ÇÑ FDG PET/CT ¿Í
gadolinium-enhanced MRI ºñ±³ Duo, J., Han, X., Zhang, L., Wang, G., Ma,
Y., & Yang, Y.
10.1097/RLU.0b013e3182817af3 2013 38 5
343-8
Utility of choline
positron emission tomography/computed tomography for lymph node involvement
identification in intermediate- to high-risk prostate cancer: a systematic
literature review and meta-analysis: [ü°èÀû°íÂû°ú ¸ÞŸºÐ¼®] Àü¸³¼±¾ÏÀÇ
¸²ÆÄÀý ÀüÀÌ Áø´ÜÀ» À§ÇÑ Choline PET/CT ÀÌ¿ë Evangelista,
L., Guttilla, A., Zattoni, F., Muzzio, P. C., & Zattoni, F. 10.1016/j.eururo.2012.09.039 2013 63 6
1040-8
Choline PET or PET/CT
and biochemical relapse of prostate cancer: a systematic review and
meta-analysis: [¸ÞŸºÐ¼®] Á÷Àå¾ÏÀüÀÌ Áø´ÜÀ» À§ÇÑ 18F-choline and 11C-choline PET or PET/CT°Ë»ç¹ý Æò°¡. Evangelista, L., Zattoni, F., Guttilla, A.,
Saladini, G., Zattoni, F., Colletti, P. M., & Rubello, D. 10.1097/RLU.0b013e3182867f3c 2013 38 5
305-14
Serum human epididymis
protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a
systematic review: [ü°èÀû°íÂû] ³¼Ò¾Ï Áø´ÜÀ» À§ÇÑ Ç÷û HE4ÃøÁ¤°ú CA-125ºñ±³. Ferraro, S., Braga, F., Lanzoni, M., Boracchi,
P., Biganzoli, E. M., & Panteghini, M. 10.1136/jclinpath-2012-201031 2013 66 4
273-81
Mini-probe
ultrasonography for the staging of colon cancer: a systematic review and
meta-analysis: [ü°èÀû °íÂû°ú ¸ÞŸºÐ¼®] ´ëÀå¾Ï ÀÓ»ó ½ºÅ×ÀÌÁö¸¦ °áÁ¤ÇÔ¿¡
ÀÖ¾î mini-probe EUSÀÇ Áø´ÜÁ¤È®¼º Æò°¡
Gall, T.
M., Markar, S. R., Jackson, D., Haji, A., & Faiz, O. 10.1111/codi.12445 2013 16 1 O1-8
18FDG PET-CT for
diagnosis of distant metastases in breast cancer patients. A meta-analysis:
[¸ÞŸºÐ¼®] À¯¹æ¾ÏÀüÀÌÁø´ÜÀ»
À§ÇÑ (18)FDG PET-CT °¡Ä¡ Æò°¡Hong, S., Li, J., & Wang, S. 10.1016/j.suronc.2013.03.001
2013 22 2 139-43
Diagnostic performance
of fluorine 18 fluorodeoxyglucose positron emission tomography imaging for
detection of primary lesion and staging of endometrial cancer patients:
systematic review and meta-analysis of the literature:[ü°èÀû°íÂû°ú ¸ÞŸºÐ¼®] Àڱ󻸷¾Ï ÁøÇà´Ü°è Áø´Ü°Ë»ç¸¦ À§ÇÑ (18)F-FDG PETÀÇ Á¤È®¼º
¿¬±¸ Kakhki, V. R., Shahriari, S., Treglia, G.,
Hasanzadeh, M., Zakavi, S. R., Yousefi, Z., Kadkhodayan, S., & Sadeghi, R. 10.1097/IGC.0000000000000003
2013 23 9 1536-43
Accuracy of fecal
immunochemical tests for colorectal cancer: systematic review and
meta-analysis:
: [ü°èÀû°íÂû°ú ¸ÞŸºÐ¼®] °áÀåÁ÷Àå¾Ï
Áø´ÜÀÇ FITs °Ë»ç Á¤È®¼º. 10.7326/M13-1484 2014 160 3 171 24658694 Lee,
J. K., Liles, E. G., Bent, S., Levin, T. R., & Corley, D. A.
Meta-analysis:
accuracy of 18FDG PET-CT for distant metastasis staging in lung cancer
patients:
patients [¸ÞŸºÐ¼®] Æó¾ÏȯÀÚÀÇ
¿ø°Å¸® ÀüÀÌ´Ü°è Áø´ÜÀ» À§ÇÑ 18FDG PET-CT Á¤È®¼º. Li, J., Xu, W., Kong, F., Sun, X., &
Zuo, X. 10.1016/j.suronc.2013.04.001 2013 22 3 151-5
Human epididymis
protein 4 for differential diagnosis between benign gynecologic disease and
ovarian cancer: a systematic review and meta-analysis: [ü°èÀû°íÂû°ú ¸ÞŸºÐ¼®] ¾ç¼ººÎÀΰúÁúȯ °ú ³¼Ò¾Ï ±¸º° Áø´ÜÀ» À§ÇÑ HE4 Áø´Ü°Ë»ç
Lin, J., Qin, J. & Sangvatanakul, V. 10.1016/j.ejogrb.2012.10.036
2013 167 1 81-5
The role of magnetic
resonance imaging in assessing residual disease and pathologic complete
response in breast cancer patients receiving neoadjuvant chemotherapy: a
systematic review: [ü°èÀû
°íÂû] ½Åº¸°ÈÇпä¹ýÀ» ¹Þ´Â À¯¹æ¾ÏȯÀÚÀÇ ÀÜ¿©Áúº´°ú º´¸®ÇÐÀû ¿Ï¼º¹ÝÀÀÀÇ »çÁ¤À» À§ÇÑ MRI ¿ªÇÒ Lobbes, M. B., Prevos, R., Smidt,
M., Tjan-Heijnen, V. C., van Goethem, M., Schipper, R., Beets-Tan, R. G., &
Wildberger, J. E. 10.1007/s13244-013-0219-y 2013 4 2 163-75
The PCA3 test for
guiding repeat biopsy of prostate cancer and its cut-off score: a systematic
review and meta-analysis: [ü°èÀû °íÂû°ú ¸ÞŸºÐ¼®] Àü¸³¼±¾Ï
Ãʱâ¹ß°ßÀ» À§ÇÑ PCA3 Å×½ºÆ® Áø´Ü¹ý Luo, Y., Gou,
X., Huang, P., & Mou, C. 10.4103/1008-682X.125390 2014 16 3 487-92
Laparoscopy for
diagnosing resectability of disease in patients with advanced ovarian cancer: ÁøÇà³¼ÒÇÔÀ» °¡Áø ȯÀÚÀÇ ÀýÁ¦°¡´É¼ºÀ» À§ÇÑ Áø´Üº¹°°æ °Ë»ç. Marianne, J. Rutten., Mariska, M. G.
Leeflang., Gemma, G. Kenter., Ben Willem, J. Mol., & Marrije, Buist 10.1002/14651858.CD009786.pub2
2014 2 2 CD009786
Fluorine-18
fluorodeoxyglucose positron emission tomography-computed tomography in
monitoring the response of breast cancer to neoadjuvant chemotherapy:[¸ÞŸºÐ¼®] ½Åº¸° ÈÇпä¹ýÀ»
¹ÞÀº À¯¹æ¾ÏȯÀÚÀÇ ¹ÝÀÀÀ» ¸ð´ÏÅ͸µÇϱâ À§ÇÑ FDG-PET Áø´Ü¼öÇà Æò°¡ Mghanga, F. P., Lan, X., Bakari, K. H., Li, C., & Zhang, Y. 10.1016/j.clbc.2013.02.003 2013 13 4 271-9
Usefulness of
F-18-fluorodeoxyglucose positron emission tomography to confirm suspected
pancreatic cancer: [¸ÞŸºÐ¼®] ÃéÀå¾Ï È®ÁøÀ» À§ÇÑ (18)FDG-PET and (18)FDG-PET/CT À¯¿ë¼º. Rijkers, A. P., Valkema, R., Duivenvoorden,
H. J., & van Eijck, C. H.10.1016/j.ejso.2014.03.016 2014 40 7
794-804
Comparison of 18 FDG
PET-CT and bone scintigraphy for detection of bone metastases in breast cancer
patients: [¸ÞŸºÐ¼®] À¯¹æ¾ÏȯÀÚÀÇ °ñÀüÀÌ Áø´ÜÀ» À§ÇÑ °ñ ¼¶±¤Á¶Çü¼ú°ú 18 FDG PET-CT ºñ±³ Rong, J., Wang, S., Ding, Q., Yun, M., Zheng, Z., & Ye, S. 10.1016/j.suronc.2013.01.002 2013 22 2
86-91
Magnetic Resonance
Imaging-targeted Biopsy May Enhance the Diagnostic Accuracy of Significant
Prostate Cancer Detection Compared to Standard Transrectal Ultrasound-guided
Biopsy: : [¸ÞŸºÐ¼®] Àü¸³¼±¾Ï
Áø´ÜÀÇ Á¤È®¼º Çâ»óÀ» À§ÇÑ Ç¥ÁØ
TRUS-Bx¿Í MRI-TBx ºñ±³. Schoots, I. G., Roobol, M. J., Nieboer, D.,
Bangma, C. H., Steyerberg, E. W., & Hunink, M. G. 10.1016/j.eururo.2014.11.037 2014
Diagnostic value of
circulating microRNAs for lung cancer: a meta-analysis: [¸ÞŸºÐ¼®] Æó¾ÏÁø´ÜÀ» À§ÇÑ microRNAs °è»êÀÇ Áø´Ü°¡Ä¡ Shen, Y., Wang, T., Yang, T., Hu, Q., Wan, C., Chen, L., & Wen,
F. 10.1089/gtmb.2012.0370 2013 17 5 359-66
Meta-analysis of 18FDG
PET-CT for nodal staging in patients with esophageal cancer:
[¸ÞŸºÐ¼®] ½Äµµ¾Ï ȯÀÚÀÇ
¼ö¼úÀü ±¹¼Ò °áÀýÀüÀÌ Áø´ÜÀ» À§ÇÑ 18FDG PET-CT °Ë»ç. Shi, W., Wang, W., Wang, J., Cheng, H.,
& Huo, X. 10.1016/j.suronc.2013.02.003 2013 22 2
112-6
Clinical assessment to
screen for the detection of oral cavity cancer and potentially malignant
disorders in apparently healthy adults: °Ç°ÇѼºÀÎÀÇ ÀáÀçÀû ¾Ç¼ºÁúȯ°ú ±¸°¾Ï ¹ß°ßÀ» À§ÇÑ ÀÓ»ó»çÁ¤
½ºÅ©¸°
Tanya, Walsh., Joseph, L. Y. Liu., Paul,
Brocklehurst., Anne?Marie, Glenny., Mark, Lingen., Alexander, R. Kerr., Graham,
Ogden., Saman, Warnakulasuriya., & Crispian, Scully 10.1002/14651858.CD010173.pub2 2013 11 11
CD010173
Sentinel node mapping
in anal canal cancer: ¸ÞŸºÐ¼®] Ç×¹®¾ÏÀÇ ÀüÃʸ²ÇÁÀý ¸ÅÇÎ
Tehranian, S., Treglia, G., Krag, D. N.,
Dabbagh Kakhki, V. R., Zakavi, S. R., Sadeghi, R., & Keshtgar, M. 2013 22 3
321-8
Sentinel node assessment for
diagnosis of groin lymph node involvement in vulval cancer: À½¹®¾ÏÀÇ ¼ÇýºÎ ¸²ÇÁÀý ¿¬·ç Áø´ÜÀ» À§ÇÑ ÀüÃʸ²ÇÁÀý »çÁ¤ Theresa, A. Lawrie., Amit, Patel., Pierre,
P. L. Martin?Hirsch., Andrew, Bryant., Nithya, D. G. Ratnavelu., Raj, Naik.,
& Angela, Ralte 10.1002/14651858.CD010409.pub2 2014 6 6 CD010409
Systematic review and
meta-analysis of cytokeratin 19-based one-step nucleic acid amplification
versus histopathology for sentinel lymph node assessment in breast cancer: [ü°èÀû°íÂû°ú ¸ÞŸºÐ¼®] À¯¹æ¾ÏÀÇ
ÀüÃʸ²ÇÁÀý »çÁ¤À» À§ÇÑ Á¤±Ô Á¶Á÷º´¸®Çаú ¼ö¼ú Áß OSNA (one-step nucleic acid
amplification) °íÂû Tiernan, J. P., Verghese, E. T., Nair, A.,
Pathak, S., Kim, B., White, J., Thygesen, H., Horgan, K., & Hanby, A. M. 10.1002/bjs.9386
2014 101 4 298-306
Predictive value of
T2-weighted imaging and contrast-enhanced MR imaging in assessing myometrial
invasion in endometrial cancer: a pooled analysis of prospective studies: Àڱ󻸷¾ÏÀÇ ÀڱñÙÀ° ħ¹ü »çÁ¤À» À§ÇÑ T2WI¿Í CE-MRI °Ë»çÀÇ ¿¹Ãø°¡Ä¡ Wu, L. M., Xu, J. R., Gu, H. Y., Hua, J.,
Haacke, E. M., & Hu, J. 10.1007/s00330-012-2609-9 2013 23 2 435-49
Role of magnetic
resonance imaging in the detection of local prostate cancer recurrence after
external beam radiotherapy and radical prostatectomy: ±¤¹üÀ§ Àü¸³»ù ÀýÁ¦¼ú°ú ¿Ü¹æ»ç¼±¹æÃâÄ¡·áÈÄÀÇ
±¹¼Ò Àü¸³¼±¾Ï Àç¹ß ¹ß°ßÀ» À§ÇÑ MRI ¿ªÇÒ Wu, L. M., Xu, J. R., Gu, H. Y., Hua, J.,
Haacke, E. M., & Hu, J., Hua, J., Zhu, J., Chen, J., Zhang, W., & Hu,
J. 10.1016/j.clon.2012.11.010 2013 25 4
252-64
The diagnostic value
of monoclonal gastric cancer 7 antigen: a systematic review with meta-analysis:
[¸ÞŸºÐ¼®] ´ÜŬ·Ð À§¾ÏÁø´ÜÀ» À§ÇÑ MG7-AgÀÇ
Áø´ÜÀû ¿ªÇÒ Zeng, Z., Fu, S., Hu, P., Zhao, L., Zhang,
H., Tang, X., Yang, X., & Zeng, Z. 10.1007/s10238-013-0246-5 2013 14 3 337-43
Assessment of the
potential diagnostic value of serum p53 antibody for cancer: [¸ÞŸºÐ¼®] ¾ÏÀÇ Ç÷û p53Ç×üÀÇ ÀáÀçÀû Áø´ÜÀû °¡Ä¡»çÁ¤ hang, J., Xu, Z., Yu, L., Chen, M., &
Li, K.
10.1371/journal.pone.0099255 2014 9 6 e99255
Combined endobronchial
and endoscopic ultrasound-guided fine needle aspiration for mediastinal lymph
node staging of lung cancer: [¸ÞŸºÐ¼®] Æä¾ÏÀÇ Á¾°Ýµ¿ ¸²ÇÁÀý ´Ü°èÀÇ EBUS-TBNA (Endobronchial ultrasound-guided transbronchial needle
aspiration)°ú EUS-FNA (Endoscopic ultrasound-guided
fine-needle aspiration) Áø´ÜÁ¤È®¼º Æò°¡
Zhang, R., Ying, K.,
Shi, L., Zhang, L., & Zhou, L. 10.1016/j.ejca.2013.02.008 2013 49 8 1860-7
Limited Diagnostic
Value of microRNAs for Detecting Colorectal Cancer: [¸ÞŸºÐ¼®] °áÀåÁ÷Àå¾Ï Áø´ÜÀ» À§ÇÑ microRNAsÀÇ Á¦ÇÑÀû Áø´ÜÀû °¡Ä¡Æò°¡ Zhou, X. J., Dong, Z. G., Yang, Y. M., Du,
L. T., Zhang, X., & Wang, C. X.
2013 14 8 4699-704
18FDG PET-CT for
detecting gastric cancer recurrence after surgical resection: [¸ÞŸºÐ¼®] ¿Ü°úÀýÁ¦¼ú
ÈÄÀÇ À§¾ÏÀç¹ß Áø´ÜÀ» À§ÇÑ 18FDG PET-CT Æò°¡ Zou, H., & Zhao, Y. 10.1016/j.suronc.2013.05.001
2013 22 3 162-6